Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
373.46
+14.46 (4.03%)
At close: Aug 13, 2025, 4:00 PM
373.46
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:30 PM EDT
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals had 528 employees as of December 31, 2024. The number of employees increased by 152 or 40.43% compared to the previous year.
Employees
528
Change (1Y)
152
Growth (1Y)
40.43%
Revenue / Employee
$976,415
Profits / Employee
-$533,900
Market Cap
8.32B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MDGL News
- 2 days ago - Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 6 days ago - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 13 days ago - Madrigal Pharmaceuticals: Rezdiffra Expansion Avenues Shift Focus To Long Term - Seeking Alpha
- 14 days ago - Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited - GlobeNewsWire
- 19 days ago - Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 - GlobeNewsWire
- 22 days ago - Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH - GlobeNewsWire